A B S T R A C T Pulmonary function studies were carried out in a group of asymptomatic nonsmoking adults with intermediate alpha-l-antitrypsin deficiency who were attending an early disease detection unit in Rochester, N. Y. All subjects were identified by specific protease inhibitor (Pi) typing. Fifteen MZ and 14 MS subjects who had never smoked cigarettes were matched by sex and age to MM controls. Spirometry, static lung volumes, and single breath-diffusing capacity were identical in all Pi type groups with no statistically significant differences noted. Maximal expiratory flow volume curves were obtained in all subjects. MZ subjects demonstrated statistically significant impaired maximal flow rates at 75%, 50%, and 25% of vital capacity compared to their MM controls. Total pulmonary resistance by the oscillometric method was measured at 3, 5, 7, and 9 cycle/s in the same subjects. Increased frequency dependence of resistance (defined as the difference between total pulmonary resistance at 3 cycle/s and 9 cycle/s) was observed in MZ subjects compared to MM controls. No differences were noted by this method in MS-MM pairs. The data suggest that detectable mechanical abnormalities are present in subjects with the MZ phenotype, even in the absence of established risk factors such as cigarette smoking and high air pollution.
INTRODUCTION
Laurell and Eriksson first described in 1963 an association between alpha-l-antitrypsin (AAT)l deficiency and pulmonary emphysema (1) . It is now known that serum AAT is inherited in a multiallelic, autosomal, codominant pattern. So far, 23 codominant protease inhibitor (Pi) alleles that determine the amount of circulating serum AAT have been described (2) . Approximately 90% of human subjects have Pi type MM with levels of alpha-l-antitrypsin of approximately 225 mg/100 ml. In contrast, subjects with the rare Pi type ZZ have serum AAT levels in the order of only 25 mg/100 ml. This ZZ state has been unequivocally associated with pulmonary emphysema characterized by onset in early adulthood (3) .
The clinical significance of intermediate levels of AAT is currently under intensive investigation. In particular, attention has been focused on individuals with Pi type MZ, who characteristically have only 55-60% of normal AAT-concentration, and Pi type MS, with 80-85% of normal values (4) . The MZ heterozygote state has been estimated to occur in about 2-5% and the MS in 6-8% of various normal populations (5) . Studies to date have not conclusively established that intermediate deficiency of AAT is an important risk factor in the pathogenesis of chronic obstructive pulmonary disease (COPD). Several factors that may have contributed to varying results have been identified. For example, in many studies, specific Pi typing has not been utilized, and only quantitative determinations of AAT have been used (6) (7) (8) . It is now known that these simpler tests cannot in all cases accurately discriminate Pi types MZ and MS from MM individuals (9) . Additionally, the individuals examined in some studies have been relatives of patients with Pi type ZZ, (10) , and therefore a familial predisposition to COPD other than AAT deficiency may have introduced an unintentional bias (11, 12) . Several studies of patients with COPD have demonstrated a higher proportion of MZ subjects than in the general population (13) . However, it has not been possible to quantitate this risk factor independently from other well-recognized factors, especially cigarette smoking.
To circumvent some of these inherent difficulties, some studies have focused on asymptomatic individuals. Utilizing specialized physiologic techniques, these studies suggest that there are detectable abnormalities of pulmonary function, even in healthy MZ subjects (10, 14 (16, 17) ; and (b) quantitative levels of AAT by a modification of the original immunologic procedure of Laurell (17) . Details of these methods have been described elsewhere (15) . In the present study, 36 MZ subjects and 60 MS subjects were identified. Of these MZ subjects 15 had never smoked cigarettes, cigars, or pipes. For this study, these individuals were matched with consecutive nonsmoking MM controls for sex and age. Of the MS subjects, 24 (19) . Functional residual capacity and airway resistance were measured in a body plethsmograph (20, 21) . Single breath carbon monoxide-diffusing capacity was determined by the methods of Ogilvie, et al. (22) . Values were expressed as a percentage of normnal values published by Bates et al. (23) . Maximal expiratory flow volume curves were obtained in all subjects with a Med-Science model 70 spirometer (Med-Science Electronics, Inc., St. Louis, Mo.) whose output was displayed on a cathode ray storage oscilloscope and photographed (24) . Maximal flow rates (Vmax) at 75%, 50%, and 25% of the forced vital capacity maneuver were calculated and the maximal expiratory flow volume curve was plotted from these three points. To correct for differences in the size of subjects, all flow rates were expressed as flow divided by the instantaneous lung volume present at that flow rate (25) . Total pulmonary resistance (RT) was measured in all subjects with a modification of the forced oscillometric technique as described by Interiano et al. (26) . RT was measured at 3 (R3), 5 (R5), 7 (R7), and 9 (R9) cycle/s. RT at resonant frequency of the subjects (RR) was between 5 and 7 cycle/s. Theoretical aspects of this procedure have been described elsewhere (27, 28 ling's T2-test (30) and multivariate signed rank tests (31) were also performed on the data and yielded essentially the same conclusions. Table I lists the pertinent characteristics of the study population and mean values for pulmonary function measurements. As previously documented, the overall sample from which these subjects were derived closely Fig. 3) . Fig. 4 demonstrates the relationship between R3-R9 (13, 32, 33) , but others have not been able to document this correlation (9, 34) . Another approach has been the study of relatively asymptomatic heterozygote populations as in the present study. Some studies have utilized offspring and siblings of severely deficient subjects with documented lung disease (10, 14) . This approach is open to the criticism that an observed higher prevalence of pulmonary function abnormalities in these samples could reflect genetic factors other than AAT deficiency (11, 12) . To avoid this source of bias, the subjects in this study were randomly selected from an We noted statistically significant diminutions in expiratory flow in MZ subjects. Other investigators, studying nonsmoking MZ relatives of ZZ individuals, have noted similar findings (10) . Second, the development of uneven airway time constants was determined by the technique of measuring total pulmonary resistance at varying frequencies. According to the theoretical work of Otis et al. (35) , both the observed airway resistance and lung compliance will fall as the frequency of airflow increases in the presence of asynchronous time constants in the lung. Recent work from our laboratory indicates that frequency dependence of total pulmonary resistance is closely correlated with frequency dependence of dynamic compliance in young adult smokers (36) . Several previous studies (14, 37) have noted frequency dependence of dynamic compliance in patients with intermediate levels of AAT. Pathogenesis of mechanical abnormalities in MZ heterozygotes The present data, along with previously published studies, permit some speculation regarding the pathophysiology of intermediate AAT deficiency. In particular the limitation in expiratory flow rates in MZ subjects was highly correlated with the presence of asynchronous time constants as measured by frequency dependence of resistance, suggesting that these two mechanical abnormalities are related to a common pathophysiological mechanism (Fig. 4) . Several alternative methods may be proposed.
RESULTS
Regional alterations in lung compliance. The frequency dependence of pulmonary resistance in this study and the frequency dependence of dynamic compliance described by others (14) in MZ subjects are presumably the sequelae of asynchronous time constants explainable by regional alterations in lung compliance. A predilection for basilar involvement has been described in severely deficient homozygous subjects by lung scanning and autopsy examination (38, 39) . If the same process were present in intermediate deficient subjects, the disease process might exaggerate the gravity-dependent regional differences in time constants present in normal lungs, thus creating true regional asynchronous time constants. Several factors reason against this hypothesis. While Fallat et al. (40) have described delayed clearance of 133Xe from the base of the lungs in intermediate deficient subjects, this finding may be related to smoking, since these regional differences were not observed in nonsmoking intermediate subjects. Moreover, theoretical considerations do not seem to fit this model. Based on the equations of Otis and coworkers (35) , the frequency-dependent characteristics of such a two-compartment lung with asynchronous time constants can be analyzed. Compliance of a twocompartment lung must differ by more than 10-fold to produce the observed changes in resistance from 3 to 9 cycle/s noted in our MZ subjects (Table IV) . In addition, an alteration in regional compliance of this order of magnitude would likely be associated with other physiologic abnormalities. For example, in pathological studies of homozygotes (Pi type ZZ) there is marked pulmonary capillary as well as parenchymal destruction in involved areas of lung (37) . Thus, the patients with intermediate deficiency would be expected to have some diminution in diffusing capacity if the disease process has a predilection for the base of the lungs. Such marked regional increases in lung compliance would also be expected to increase residual volume, impair distribution of ventilation, and increase closing volumes. Since these types of abnormalities have only been seen in a small proportion of MZ subjects drawn from a smoking population (10), regional loss of elastic recoil is not a satisfactory explanation for the mild abnormalities found in our nonsmoking MZ subjects. Mead (41) first pointed out that frequency-dependent behavior of the lungs can be present in the absence of peripheral parenchymal time-constant discrepancies, as described in the classic Otis et al. model (35) . He showed that if the lung is divided into two compartnents, one containing the central conducting airways with low compliance, and the other containing the more compliant peripheral airways, a rise in peripheral resistance will cause the pattern of frequency dependence of resistance and compliance seen in human disease states. Fig. 5A shows how this model of uneven time constants between conducting airways and lung parenchyma results in frequency dependence of resistance when peripheral airway resistance increases. It also shows that if loss of elastic recoil results in a rise in compliance of the peripheral airways without a rise in peripheral resistance, the resultant increase in airway time constants would not produce frequency dependence of resistance. Alternatively, a rise in compliance of the more central conducting airways will result in frequency dependence of resistance and compliance (Fig. SB) . These ingenious explanations for frequency dependence of resistance and compliance imply that two basic physiological alterations may cause the frequency dependence of resistance seen in the MZ subjects (41, 42) . First, there may be a rise in peripheral resistance but not of peripheral compliance. Second, there could be an increase in compliance of the conducting airways such as might result from loss of elastic support or an alteration in the intrinsic properties of these airways. Either mechanism would result in limitation of maximal expiratory flow rates. Currently available data in MZ subjects do not permit a distinction between these two mechanisms.
The hypothesis that mechanical abnormalities in MZ subjects reflect generalized rather than regional abnormalities in lung structure and function is consistent with biochemical data regarding the relationship of AAT and pulmonary emphysema. While there is no direct biochemical evidence linking deficiency of protease inhibitors and human emphysema (43), enzymatic alteration ofconnective tissue of the lung, particularly elastin, remains a possibility. For example, AAT inhibits human granulocytic proteases, including both an elastase and a collagenase (44) . Deficiency of AAT might lead to increased levels of enzymes and destruction of lung tissue.
The clinical significance of these physiologic abnormalities described remains unclear. Prospective studies would be needed to determine if these subjects will eventually develop symptomatic lung disease. Others have recently pointed out that cigarette smoking may be the significant determinant of the development of COPD in MZ heterozygotes (45, 46) . 
